Trial intelligence / Profile preview

AL vs DP for Uncomplicated Malaria in Guinea-Bissau

NCT04897919Phase 4Completed

Sponsor
Bandim Health Project
Start
Aug 2015
Primary completion
Oct 2017
Modality
Bivalent/Multivalent Binders, Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of dihydroartemisinin + piperaquine in Plasmodium falciparum malaria, sponsored by Bandim Health Project. Started Aug 2015; status: completed.

02

Drugs

dihydroartemisinin + piperaquine
03

Conditions

Plasmodium falciparum malaria

Beyond the preview

Go deeper on NCT04897919.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04897919.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call